LifeStance Health Group, Inc. Stock-Based Compensation
LifeStance Health Group, Inc. (LFST) reported Stock-Based Compensation of $34.95 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-06
- LifeStance Health Group, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $19.75M, a 6.48% decline year-over-year.
- LifeStance Health Group, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $15.20M, a 18.20% decline year-over-year.
- LifeStance Health Group, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $16.70M, a 3.46% increase year-over-year.
- LifeStance Health Group, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $18.30M, a 22.84% increase year-over-year.
- LifeStance Health Group, Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $74.70M, a 1.93% decline from fiscal 2024.
- LifeStance Health Group, Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $76.17M, a 23.36% decline from fiscal 2023.
- LifeStance Health Group, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $99.39M, a 46.97% decline from fiscal 2022.
- LifeStance Health Group, Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $187.43M, a 27.76% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 4 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $19.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $34.95M 10-Q · filed 2026-08-06 | $51.65M derived: sum of 3 quarters · filed 2026-08-06 | $69.95M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | $15.20M 10-Q · filed 2026-05-07 | $31.91M derived: sum of 2 quarters · filed 2026-05-07 | $50.20M derived: sum of 3 quarters · filed 2026-05-07 | $71.32M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | $16.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $35.00M derived: sum of 2 quarters · filed 2026-02-25 | $56.12M derived: sum of 3 quarters · filed 2026-08-06 | $74.70M 10-K · filed 2026-02-25 | |
| 2025-09-30 | $18.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $39.41M derived: sum of 2 quarters · filed 2026-08-06 | $58.00M 10-Q · filed 2025-11-06 | $74.14M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | $21.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $39.70M 10-Q · filed 2026-08-06 | $55.85M derived: sum of 3 quarters · filed 2026-08-06 | $70.74M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $18.58M 10-Q · filed 2026-05-07 | $34.73M derived: sum of 2 quarters · filed 2026-05-07 | $49.63M derived: sum of 3 quarters · filed 2026-05-07 | $74.17M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | $16.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $31.04M derived: sum of 2 quarters · filed 2026-02-25 | $55.59M derived: sum of 3 quarters · filed 2026-02-25 | $76.17M 10-K · filed 2026-02-25 | |
| 2024-09-30 | $14.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $39.45M derived: sum of 2 quarters · filed 2025-11-06 | $60.03M 10-Q · filed 2025-11-06 | $80.94M derived: sum of 4 quarters · filed 2026-02-25 | |
| 2024-06-30 | $24.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $45.13M 10-Q · filed 2025-08-07 | $66.05M derived: sum of 3 quarters · filed 2026-02-25 | $87.58M derived: sum of 4 quarters · filed 2026-02-25 | |
| 2024-03-31 | $20.58M 10-Q · filed 2025-05-07 | $41.50M derived: sum of 2 quarters · filed 2026-02-25 | $63.02M derived: sum of 3 quarters · filed 2026-02-25 | $96.10M derived: sum of 4 quarters · filed 2026-02-25 | |
| 2023-12-31 | $20.92M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $42.44M derived: sum of 2 quarters · filed 2026-02-25 | $75.52M derived: sum of 3 quarters · filed 2026-02-25 | $99.39M 10-K · filed 2026-02-25 | |
| 2023-09-30 | $21.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $54.60M derived: sum of 2 quarters · filed 2024-11-07 | $78.47M 10-Q · filed 2024-11-07 | $113.66M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-06-30 | $33.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $56.94M 10-Q · filed 2024-08-08 | $92.14M derived: sum of 3 quarters · filed 2025-02-27 | $127.01M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-03-31 | $23.87M 10-Q · filed 2024-05-09 | $59.06M derived: sum of 2 quarters · filed 2025-02-27 | $93.93M derived: sum of 3 quarters · filed 2025-02-27 | $151.44M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2022-12-31 | $35.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $70.06M derived: sum of 2 quarters · filed 2025-02-27 | $127.58M derived: sum of 3 quarters · filed 2025-02-27 | $187.43M 10-K · filed 2025-02-27 | |
| 2022-09-30 | $34.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $92.38M derived: sum of 2 quarters · filed 2023-11-08 | $152.24M 10-Q · filed 2023-11-08 | $260.87M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2022-06-30 | $57.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $117.36M 10-Q · filed 2023-08-09 | $226.00M derived: sum of 3 quarters · filed 2024-02-28 | $346.68M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2022-03-31 | $59.85M 10-Q · filed 2023-05-10 | $168.49M derived: sum of 2 quarters · filed 2024-02-28 | $289.17M derived: sum of 3 quarters · filed 2024-02-28 | $318.69M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2021-12-31 | $108.63M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $229.32M derived: sum of 2 quarters · filed 2024-02-28 | $258.83M derived: sum of 3 quarters · filed 2024-02-28 | $259.44M 10-K · filed 2024-02-28 | |
| 2021-09-30 | $120.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $150.20M derived: sum of 2 quarters · filed 2022-11-09 | $150.81M 10-Q · filed 2022-11-09 | $151.40M derived: sum of 4 quarters · filed 2023-03-09 | |
| 2021-06-30 | $29.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $30.12M 10-Q · filed 2022-08-10 | $30.71M derived: sum of 3 quarters · filed 2023-03-09 | $31.28M derived: sum of 4 quarters · filed 2023-03-09 | |
| 2021-03-31 | $605.00K 10-Q · filed 2022-05-11 | $1.19M derived: sum of 2 quarters · filed 2023-03-09 | $1.76M derived: sum of 3 quarters · filed 2023-03-09 | $2.06M derived: sum of 4 quarters · filed 2023-03-09 | |
| 2020-12-31 | $587.00K derived: 10-K 9 month − 10-Q 6 month · filed 2023-03-09 | $1.16M derived: sum of 2 quarters · filed 2023-03-09 | $1.45M 10-K · filed 2023-03-09 | ||
| 2020-09-30 | $573.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-11-10 | $865.00K 10-Q · filed 2021-11-10 | |||
| 2020-06-30 | $292.00K 10-Q · filed 2021-08-12 | ||||
| 2020-05-14 | $0.00 10-K · filed 2023-03-09 | ||||
| 2019-12-31 | $54.00K 10-K · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |